Lung Cancer
Volume 70, Issue 2 , Pages 129-135 , November 2010

A bibliometric analysis of scientific production in mesothelioma research

  • Donatella Ugolini

      Affiliations

    • Dipartimento di Oncologia, Biologia e Genetica, University of Genoa, Genoa, Italy
    • Unit of Epidemiology and Biostatistics, National Cancer Research Institute, Genoa, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Oncologia, Biologia e Genetica, University of Genoa, Istituto Nazionale per la ricerca sul cancro, Largo R. Benzi, 10, 16132 Genoa, Italy. Tel.: +39 010 5737421; fax: +39 010 354103.
    • ,
  • Monica Neri

      Affiliations

    • Unit of Molecular Epidemiology, National Cancer Research Institute, Genoa, Italy
    • ,
  • Cristina Casilli

      Affiliations

    • Dipartimento di Oncologia, Biologia e Genetica, University of Genoa, Genoa, Italy
    • ,
  • Marcello Ceppi

      Affiliations

    • Unit of Molecular Epidemiology, National Cancer Research Institute, Genoa, Italy
    • ,
  • Pier Aldo Canessa

      Affiliations

    • Unit of Pneumology, Ospedale San Bartolomeo, Sarzana, Italy
    • ,
  • Giovanni Paolo Ivaldi

      Affiliations

    • Unit of Pneumology, Azienda Ospedaliera Villa Scassi, Genoa, Italy
    • ,
  • Michela Paganuzzi

      Affiliations

    • Unit of Clinical Pathology, National Cancer Research Institute, Genoa, Italy
    • ,
  • Stefano Bonassi

      Affiliations

    • Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Rome, Italy

Received 29 July 2009 ,Revised 23 December 2009 ,Accepted 19 January 2010.

References 

  1. Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366:397–408
  2. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007;45(3):379–387
  3. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control. 2003;14:791–803
  4. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000;57:488–494
  5. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;4:535–539
  6. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer. 2004;8:1022–1024
  7. Doll R, Peto J. Asbestos effects on health of exposure to asbestos. Review for the Health and Safety Commission. London, UK: HSE Books; 1985;
  8. Michalopoulos A, Falagas ME. A bibliometric analysis of global research production in respiratory medicine. Chest. 2005;128:3993–3998
  9. Rahman M, Haque TL, Fukui T. Research articles published in clinical radiology journals: trend of contribution from different countries. Acad Radiol. 2005;12:825–829
  10. Falagas ME, Karavasiou AI, Bliziotis IA. Estimates of global research productivity in virology. J Med Virol. 2005;76:229–233
  11. Cimmino MA, Maio T, Ugolini D, Borasi F, Mela GS. Trends in otolaryngology research during the period 1995–2000: a bibliometric approach. Otolaryngol Head Neck Surg. 2005;132:295–302
  12. Ugolini D, Mela GS. Oncological research overview in the European Union. A 5-year survey. Eur J Cancer. 2003;39:1888–1894
  13. Grossi F, Belvedere O, Rosso R. Geography of clinical cancer research publications from 1995 to 1999. Eur J Cancer. 2003;39:106–111
  14. Ugolini D, Cimmino MA, Casilli C, Mela GS. How the European Union writes about ophthalmology. Scientometrics. 2001;52:45–58
  15. Mela GS, Cimmino MA. An overview of rheumatological research in the European Union. Ann Rheum Dis. 1998;57:643–647
  16. National Library of Medicine, Bethesda, MD, USA. 2005. PubMed manual. Available at: http://www.nlm.nih.gov/pubs/manuals/pubmed.pdf.
  17. Eurostat. Research and development: annual statistics, 2000. Belgium, 1996–2000.
  18. International Monetary Fund, Washington, D.C. accessed January/February 2009. Available at: http://www.imf.org.
  19. US Census Bureau, accessed January/February 2009. Available at: http://www.census.gov.
  20. United States, National Library of Medicine, National Institute of Health. Search strategy used to create the cancer subset on PubMed, accessed January/February 2009. Available at: http://www.nlm.nih.gov/bsd/pubmed_subsets/cancer_strategy.html.
  21. World Health Organization. Who mortality database, accessed March 2009. Available at: http://www.who.int/healthinfo/morttables/en/index.html.
  22. Cameron AC, Trivedi PK. Regression analysis of count data. Cambridge, UK: Cambridge University Press; 1998;
  23. Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003;362:1612–1616
  24. Fennell DA, Gaudino G, O’Byrne KJ, Mutti L, van Meerbeeck J. Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol. 2008;5:136–147
  25. Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res. 2008;659:126–136
  26. Pass HI, Kennedy RC, Carbone M. Evidence for and implications of SV40-like sequences in human mesotheliomas. Important Adv Oncol. 1996;89–108
  27. Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7:147–154
  28. Ugolini D, Puntoni R, Perera FP, Schulte PA, Bonassi S. A bibliometric analysis of scientific production in cancer molecular epidemiology. Carcinogenesis. 2007;28:1774–1779
  29. Partridge MR, Lewison G. Respiratory research output. Chest. 2006;130:1283
  30. García-Río F, Serrano S, Dorgham A, Alvarez-Sala R, Ruiz Peña A, Pino JM, et al. A bibliometric evaluation of European Union research of the respiratory system from 1987–1998. Eur Respir J. 2001;17:1175–1180
  31. Garfield E. The history and meaning of the journal impact factor. JAMA. 2006;295:90–93
  32. Hakansson A. The impact factor—a dubious measure of scientific quality. Scand J Prim Health Care. 2005;23:193–194
  33. Kam PC. Impact factor: overrated and misused?. Anaesth Intensive Care. 2005;33:565–566

PII: S0169-5002(10)00027-9

doi: 10.1016/j.lungcan.2010.01.013

Lung Cancer
Volume 70, Issue 2 , Pages 129-135 , November 2010

Article Tools

* Image Usage & Resolution